Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns
GHDx Entry last modified on: Apr 10, 2023
Data by Data Type
Survey on Mental Health Status in Iranian Population Aged 15 and Above One Year after the Outbreak of COVID-19 Disease: A Population-Based Study
GHDx Entry last modified on: Apr 10, 2023
Structure, Process, and Mortality Associated with Acute Coronary Syndrome Management in Guatemala's National Healthcare System: The ACS-GT Registry
GHDx Entry last modified on: Dec 12, 2023
Sickle Cell Anaemia among Tharu Population Visiting the Outpatient Department of General Medicine in a Secondary Care Centre: A Descriptive Cross-sectional Study
GHDx Entry last modified on: May 23, 2024
Seroprevalence of COVID-19 in Niger State. Preprint
GHDx Entry last modified on: Mar 4, 2024
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
GHDx Entry last modified on: Jan 31, 2024
Serological identification of past and recent SARS-CoV-2 infection through antibody screening in Luanda, Angola
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
GHDx Entry last modified on: Jun 24, 2022
Stratifying malaria receptivity in Bangladesh using archived rapid diagnostic tests
GHDx Entry last modified on: Apr 10, 2023
Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study
GHDx Entry last modified on: May 23, 2024
Short-term impact of COVID-19 pandemic on low back pain: data from the PAMPA Cohort, Brazil
GHDx Entry last modified on: Oct 23, 2024
SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria
GHDx Entry last modified on: Mar 14, 2022
Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 Seroprevalence Study in Pimpri-Chinchwad, Maharashtra, India Coinciding with Falling Trend - Do the Results Suggest Imminent Herd Immunity? Preprint
GHDx Entry last modified on: Mar 14, 2022
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020
GHDx Entry last modified on: May 12, 2022
Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities
GHDx Entry last modified on: May 12, 2022
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study
GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys
GHDx Entry last modified on: Mar 14, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jan 31, 2024
Serologic response to SARS-CoV-2 in an African population
GHDx Entry last modified on: May 12, 2022
Sero-prevalence Findings from Metropoles in Pakistan: Implications for Assessing COVID-19 Prevalence and Case-fatality within a Dense, Urban Working Population. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021
GHDx Entry last modified on: Mar 14, 2022
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
GHDx Entry last modified on: Jan 31, 2024
Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of anti-HEV IgG in children: very early exposure in young children in a hyperendemic region
GHDx Entry last modified on: Oct 30, 2024
Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Bulgaria
GHDx Entry last modified on: Mar 25, 2025
Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and perspectives
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>
GHDx Entry last modified on: May 12, 2022
Pages
Subscribe
